Detalles de la búsqueda
1.
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors.
Breast Cancer Res Treat
; 204(3): 643-647, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224427
2.
Autoimmune Skin Diseases and Immune Checkpoint Inhibitors.
Crit Rev Immunol
; 42(3): 11-22, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017623
3.
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients.
Br J Dermatol
; 187(6): 962-969, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861701
4.
Non-infectious granulomatous disorders of the upper lip: clinicopathological analysis of 11 patients.
BMC Oral Health
; 22(1): 173, 2022 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35545768
5.
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.
Oncologist
; 26(2): e316-e326, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33021006
6.
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.
Breast Cancer Res Treat
; 185(1): 247-253, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914354
7.
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group.
J Am Acad Dermatol
; 84(5): 1310-1320, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33279646
8.
Oral mucosal changes induced by adjuvant endocrine therapies in breast cancer patients: clinical aspects and proposal for management.
Support Care Cancer
; 29(4): 1719-1722, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140247
9.
Dermatological toxicities induced by T-cell-redirecting G protein-coupled receptor family C class 5 member D bispecific antibody talquetamab.
J Am Acad Dermatol
; 90(2): 376-377, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37742842
10.
Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients.
J Am Acad Dermatol
; 90(2): 429-432, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37844688
11.
Are topical beta-blockers really effective "in real life" for targeted therapy-induced paronychia.
Support Care Cancer
; 27(7): 2341-2343, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30847700
12.
Assessment of Seasonality in Eosinophilic Dermatosis of Haematological Malignancy.
Acta Derm Venereol
; 104: adv15768, 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372473
13.
Skin toxicity of enfortumab vedotin: Proposal of a specific management algorithm.
J Eur Acad Dermatol Venereol
; 38(1): e99-e101, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607297
14.
Clinical characterization and treatment outcomes of follicular cutaneous immune-related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective study.
J Am Acad Dermatol
; 88(3): 718-720, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152697
15.
Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF-V600 + MEK Inhibitors for Advanced Melanoma.
Dermatology
; 234(3-4): 92-98, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30110681
16.
Supportive oncodermatology practices in Europe and the USA.
J Eur Acad Dermatol Venereol
; 2023 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38058268
17.
No detection of Merkel cell polyomavirus in oral lichen planus: Results of a preliminary study in a French cohort of patients.
J Med Virol
; 89(11): 2055-2057, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28661003
18.
Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey.
Br J Dermatol
; 187(6): 1054-1056, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047980
19.
Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.
J Am Acad Dermatol
; 77(5): 902-910.e2, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28918974
20.
Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
J Am Acad Dermatol
; 87(2): e85-e88, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35526651